Write a reviewFor vendors
♡
Home / Investors / Nicholas Crossfield

Nicholas Crossfield

Angel Investor · England

About Nicholas Crossfield

Angel investor (Angel Investor) based in United Kingdom. Focus areas include Drug Discovery. Invests at early stage venture stage. Past investments include Kroll Talbot Hughes, Alstom UK & Ireland, Adaptimmune Therapeutics.

Investment focus

Stages
Early Stage Venture
Sectors
Drug Discovery

Portfolio

No portfolio companies recorded yet; Nicholas Crossfield reports 4 investments overall.

Similar investors

Alexis Frentz

Venture Fund · Paris
SeedEarly Stage VentureAdvertisingHealth CareCommercialDrug Discovery+16
60Investments
—Exits

Anna Chen

Venture Fund · San Diego
Early Stage VentureLate Stage VentureHealth CareRegenerative MedicineDrug DiscoveryWellness+16
60Investments
—Exits

Anne-Sophie CARRESE

Venture Fund · Paris
SeedEarly Stage VentureAdvertisingHealth CareCommercialDrug Discovery+16
60Investments
—Exits

Annie Mitsak

Venture Fund · Boston
SeedEarly Stage VentureHealth CareDrug DiscoveryGeneticsAutoimmune Diseases+16
60Investments
—Exits

Anthony Wiemelt

Accelerator · Philadelphia
SeedEarly Stage VentureHealth CareResearch and DevelopmentRegenerative MedicineHospitals+16
60Investments
—Exits

Avak Kahvejian

Venture Fund · Cambridge
Early Stage VentureSeries ACreative VentureClean TechHealth CareResearch and Development+16
60Investments
—Exits